Dosidal · Belgium

Leflunomide AB 20 mg

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketBelgium
Recordbe:presentation:cti:660430-05 (version 1)
Levelpresentation
Pack codenot anchored
Identifiersbe-cti-extended: 660430-05
be-authorisation: BE660430
Source authorityFAMHP
Read date2026-11-15T03:58:09Z
authorisation statusamp_status: AUTHORIZED
ampp_status: AUTHORIZED
commercialised_now: False
lifecycle: current
period_from: 2022-08-17
supply_problem_now: False
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
controlled status
state: unknown
identityamp_code: SAM660429-00
atc: L04AK01
authorisation_number: BE660430
cti_extended: 660430-05
form: Film-coated tablet
holder: Aurobindo
medicine_type: ALLOPATHIC
name: Leflunomide AB 20 mg
pack: 90
parallel_circuit: 0
parallel_import: False
substances: strength: 20.0000 mg
substance: Leflunomide
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
pack product codefmd_in_scope: True
note: no FMD product code and no CNK in SAM
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
prescription classas_published: Restricted medical prescription Sp1 - Art 6, §1 bis, 2nd paragraph, 4th indent and 7th paragraph, 2) Law 25/03/1964 + Art 63 Royal Decree 14/12/2006 Delivery possible in public pharmacy, first prescription by specialist, follow-up prescription by general practitioner
class: prescription
delivery_modus: M42
specification: Sp1
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
OxvVZCnx86nmSfv2BivgCv6eyczgzauAy4oR-IruUDFasvXFT1YfxV9ovYA68pcroMgj4tm4yfP7VSydMDdn8g
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/be:presentation:cti:660430-05 · Same medicine in other markets · Dosidal